Recent progress in the medicinal chemistry of 2,4-diaminopyrimidines.
D000595:Amino Acid Sequence; D000818:Animals; D005493:Folic Acid Antagonists; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D008288:Malaria / Q000188:drug therapy; D008433:Mathematics; D008727:Methotrexate / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D008956:Models, Chemical; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use; D013237:Stereoisomerism; D014227:Triazines / Q000627:therapeutic use
D005493:Folic Acid Antagonists; D005971:Glutamates; D011743:Pyrimidines; D011799:Quinazolines; D014227:Triazines; C017205:2,4-diaminopyrimidine; C013474:2,4-diaminoquinazoline; D018698:Glutamic Acid; D008727:Methotrexate; D011739:Pyrimethamine